Natural Capsules Limited (NATCAPSUQ) reports strong Q1FY27 results with revenue of ₹48.71 Cr and EBITDA margins of 2.30%.
Amrutanjan Health Care Limited reports Q1 FY27 results with a 9.48% revenue increase, driven by double-digit growth in Women’s Hygiene.
Suraksha Diagnostic Limited (SURAKSHA) reports strong Q1 FY27 performance with PAT up 40% and EBITDA up 28%.
Jeena Sikho Lifecare Limited (NSE: JSLL) stock price fell 5% intraday to ₹508.45 as it broke below its support line, indicating a trendline breakdown.
Ind-Swift Laboratories Limited (INDSWFTLAB) reports strong Q1 FY27 results with operating EBITDA up 2.85x YoY, PAT up 2.04x YoY.
Vijaya Diagnostic Centre Limited (NSE: VIJAYA) stock breaks out, gaining 5% intraday to ₹1502.0, clearing its 6M resistance trendline.
Caplin Point Laboratories Limited (NSE: CAPLIPOINT) experiences a 5% intraday decline to ₹2493.9, breaking below its support line in the Healthcare sector.
Marksans Pharma Limited (MARKSANS) stock breaks out with an 11% intraday gain, clearing its 6M resistance trendline.
Marksans Pharma Limited (MARKSANS) reports record Q1FY27 results with EBITDA up 113% YoY, PAT up 174% and highest-ever revenue in UK & Europe.
Marksans Pharma Limited (MARKSANS) stock price gains 8% intraday, breaks out from its 6-month resistance trendline. Current price at ₹303.85.